Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial.

Source:http://linkedlifedata.com/resource/pubmed/id/21252013

Download in:

View as

General Info

PMID
21252013